Currently available methods for platelet function analysis: Advantages and disadvantages

Cardiovascular Revascularization Medicine

Volumn 12, Issue 5, 2011, Pages 312-322

  Pakala, Rajbabu ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Platelet aggregation; Platelet function; Platelet test

Indexed keywords

11 OXOTHROMBOXANE B2; ACETYLSALICYLIC ACID; THROMBOXANE;

ANALYZER; ANTICOAGULANT THERAPY; BLEEDING; BLEEDING TIME; BLOOD; BLOOD CELL COUNT; BLOOD CLOT RETRACTION; BLOOD CLOTTING; BLOOD SMEAR; BLOOD VOLUME; CELL SECRETION; CELL SHAPE; COST BENEFIT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GOROG THROMBOSIS TEST; HEMOSTASIS; HUMAN; IMMUNOASSAY; LABORATORY TEST; LUMINESCENCE; MOLECULAR MECHANICS; PLATELET ADHESION ASSAY; POINT OF CARE TESTING; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; REVIEW; RISK ASSESSMENT; SCREENING TEST; SHEAR STRESS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; THROMBOSIS;

BIOLOGICAL MARKERS; EQUIPMENT DESIGN; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS;

EID: 80052540629     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2010.09.005     Document Type: Review

References (59)

1. George JN Platelets. Lancet 2000, 355:1531-1539.
2. Collet JP, Montalescot G Platelet function testing and implications for clinical practice. J Cardiovasc Pharmacol Ther 2009, 14:157-169.
3. Jennings LK Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 2009, 102:248-257.
4. Puddu P, Muscari A, Puddu GM, Cravero E, Giannoni C, Zoli M The complexity of platelet metabolism and its contribution to atherothrombosis. Acta Cardiol 2009, 64:157-165.
5. Gawaz M, Langer H, May AE Platelets in inflammation and atherogenesis. J Clin Invest 2005, 115:3378-3384.
6. Harrison P Platelet function analysis. Blood Rev 2005, 1:111-123.
7. Oestreich JH, Smyth SS, Campbell CL Platelet function analysis: at the edge of meaning. Thromb Haemost 2009, 101:217-219.
8. Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists. Catheter Cardiovasc Interv 2009, 73:1-14.
9. Brecher G, Cronkite EP Morphology and enumeration of human blood platelets. J Appl Physiol 1950, 3:365-377.
10. Brecher G, Schneiderman M, Cronkite EP The reproducibility and constancy of the platelet count. Am J Clin Pathol 1953, 23:15-26.
11. Mundschenk DD, Connelly DP, White JG, Brunning RD An improved technique for the electronic measurement of platelet size and shape. J Lab Clin Med 1976, 88:301-315.
12. Bull BS, Schneiderman MA, Brecher G Platelet counts with the Coulter counter. Am J Clin Pathol 1965, 44:678-688.
13. Bessman JD, Williams LJ, Gilmer PR Mean platelet volume. The inverse relation of platelet size and count in normal subjects, and an artifact of other particles. Am J Clin Pathol 1981, 76:289-293.
14. Kunicka JE, Fischer G, Murphy J, Zelmanovic D Improved platelet counting using two-dimensional laser light scatter. Am J Clin Pathol 2000, 114:283-289.
15. Harrison P, Segal H, Briggs C, Murphy M, Machin S Impact of immunological platelet counting (by the platelet/RBC ratio) on haematological practice. Cytometry B Clin Cytom 2005, 67:1-5.
16. Duke WW The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and the coagulation time and report of three cases of hemorrhagic disease relieved by blood transfusion. JAMA 1910, 55:1185-1192.
17. Harker LA, Slichter SJ The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972, 287:155-159.
18. Nilsson IM, Magnusson S, Borchgrevink C The Duke and Ivy methods for determination of the bleeding time. Thromb Diath Haemorrh 1963, 10:223-234.
19. Peterson P, Hayes TE, Arkin CF, Bovill EG, Fairweather RB, Rock WA, Triplett DA, Brandt JT The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998, 133:134-139.
20. Born GV Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962, 194:927-929.
21. O'Brien JM Platelet aggregation. II. Some results from a new method of study. J Clin Pathol 1962, 15:452-481.
22. Zhou L Schmaier AH Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field. Am J Clin Pathol 2005, 123:172-183.
23. Cardinal DC, Flower RJ The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980, 3:135-158.
24. Feinman RD, Lubowsky J, Charo I, Zabinski MP The lumiaggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets. J Lab Clin Med 1977, 90:125-129.
25. White MM, Foust JT, Mauer AM, Robertson JT, Jennings LK Assessment of lumiaggregometry for research and clinical laboratories. Thromb Haemost 1992, 67:572-577.
26. Nieuwenhuis HK, Akkerman JWN, Sixma JJ Patients with prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on 106 patients. Blood 1987, 70:620-623.
27. Israels SJ, McNicol A, Robertson C, Gerrard JM Platelet storage pool deficiency: diagnosis in patients with prolonged bleeding times and normal platelet aggregation. Br J Haematol 1990, 75:118-121.
28. Coller BS, Lang D, Scudder LE Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade. Circulation 1997, 95:860-867.
29. Smith JW, Steinhubl SR, Lincoff AM, Coleman JC, Lee TT, Hillman RS, Coller BS Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation 1999, 99:620-625.
30. Wu KK, Hoak JC A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974, 2:924-926.
31. Werkum JW, Kleibeuker M, Postma S, Bouman HJ, Elsenberg EH, Ten Berg JM, Hackeng CM A comparison between the Plateletworks - assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel. Int J Cardiol 2010, 140:123-126.
32. White MM, Krishnan R, Kueter TJ, Jacoski MV, Jennings LK The use of the point of care Helena ICHOR/Plateletworks and the Accumetrics Ultegra RPFA for assessment of platelet function with GPIIB-IIIa antagonists. J Thromb Thrombolysis 2004, 18:163-169.
33. Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RCL Comparison of modified thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med 2005, 14:309-315.
34. Goldsmith HL, Turitto VT Rheological aspects of thrombosis and haemostasis: basic principles and applications. Thromb Haemost 1986, 5:415-435.
35. Sakariassen KS, Hanson SR, Cadroy Y Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy. Thromb Res 2001, 104:149-174.
36. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA Description of an in vitro platelet function analyzer - PFA-100. Semin Thromb Hemost 1995, 21(Suppl 2):106-112.
37. Jilma B Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001, 138:152-163.
38. Favaloro EJ Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia 2001, 7:170-179.
39. Francis JL Platelet Function Analyzer (PFA-100). Platelets 2004, 325-335. Academic Press, San Diego (CA). A.D. Michelson (Ed.).
40. Einav S, Dewey CF, Hartenbaum H Cone and plate apparatus: a compact system for studying well characterized flow fields. Exper Fluids 1994, 16:196-202.
41. Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997, 85:283-294.
42. Shenkman B, Savion N, Dardik R, Tamarin I, Varon D Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thromb Res 2000, 99:353-361.
43. Varon D, Savion N Cone and plate(let) analyzer. Platelets 2004, 337-345. Academic Press, San Diego (CA). A.D. Michelson (Ed.).
44. Bochsen L, Wiinberg B, Kjelgaard-Hansen M, Steinbruchel DA, Johansson PI Evaluation of the TEG platelet mapping assay in blood donors. Thromb J 2007, 5:3.
45. Chandler WL The thromboelastography and the thromboelastograph technique. Semin Thromb Hemost 1995, 21(Suppl 4):1-6.
46. Bowbrick VA, Mikhailidis DP, Stansby G Value of thromboelastography in the assessment of platelet function. Clin Appl Thromb Hemost 2003, 9:137-142.
47. Michelson AD, Linden MD, Barnard MR, Furman MI, Frelinger AL Flow cytometry. Platelets 2007, 545-564. Elsevier/Academic Press, San Diego (CA). 2nd ed. Michelson (Ed.).
48. Shattil SJ, Hoxie JA, Cunningham M, Brass LF Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 1985, 260:11107-11114.
49. McEver RP P-Selectin/PSGL-1 and other interactions between platelets, leukocytes, and endothelium. Platelets 2007, 231-249. Elsevier/Academic Press, San Diego (CA). 2nd ed. A.D. Michelson (Ed.).
50. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001, 104:1533-1537.
51. Cattaneo M The platelet P2 receptors. Platelets 2007, 201-220. Elsevier/Academic Press, San Diego (CA). 2nd ed. A.D. Michelson (Ed.).
52. Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005, 3:85-92.
53. Schwarz UR, Geiger J, Walter U Eigenthaler MFlow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets - definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 1999, 82:1145-1152.
54. Michelson AD, Furman MI Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol 1999, 6:342-348.
55. Grosser T, Fries S, FitzGerald GA Thromboxane generation. Platelets 2007, 565-574. Elsevier/Academic Press, San Diego (CA). 2nd ed. A.D. Michelson (Ed.).
56. Fitzpatrick FA, Gorman RR, Mc Guire JC, Kelly RC, Wynalda MA, Sun FF A radioimmunoassay for thromboxane B2. Anal Biochem 1977, 82:1-7.
57. Kumlin M, Granstrom E Radioimmunoassay for 11-dehydro-TXB2: A method for monitoring thromboxane production in vivo. Prostaglandins 1986, 32:741-767.
58. Fitzpatrick FA, Gorman RR, Wynalda MA Electron capture gas chromatographic detection of thromboxane B2. Prostaglandins 1977, 13:201-208.
59. Lawson JA, Patrono C, Ciabattoni G, Fitzgerald GA Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Anal Biochem 1986, 155:198-205.